Experience

On June 29, 2017, Davis Polk achieved a total victory in a litigation filed in New York state court against its client Consolidated Edison, Inc.The case against Con Edison, captioned …

Davis Polk advised the joint book-running managers on an SEC-registered offering by General Motors Financial Company, Inc. of $500 million aggregate principal amount of floating-rate senior…

Davis Polk advised Compass Bank, a wholly owned subsidiary of BBVA Compass Bancshares, Inc., in connection with the offering of $750 million aggregate principal amount of its 2.875% senior…

Davis Polk advised the joint lead managers in connection with the $600 million Regulation S offering by Shui On Development (Holding) Limited of its 6.40% senior perpetual capital…

Davis Polk is advising Dyal Capital Partners, a division of Neuberger Berman Group, on its strategic minority investment in Atalaya Capital Management. Dyal will become a passive, non…

Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with its acquisition by a wholly owned subsidiary of Royal Philips,…

Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Teladoc, Inc. of $275 million aggregate principal amount of its 3.00% convertible senior notes due 2022…

Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875% notes due 2036, 6.125% notes due 2038 and 6.875% debentures due…

Davis Polk advised Hilong Holding Limited on its $250 million Regulation S offering of 7.25% senior notes due 2020. The notes were guaranteed by certain offshore subsidiaries of Hilong. The…